Tag: RelabotulinumtoxinA
Galderma boosts biologics manufacturing with new Swedish licence approvals
Galderma has secured manufacturing license updates from the Swedish Medical Products Agency, enabling the company to advance its ambitious growth and innovation agenda.
Featured Article
Navigating energy price volatility with predictive intelligence
Energy price volatility has become a structural feature of modern electricity markets rather than a temporary disruption. For energy-intensive manufacturers and large commercial operators, fluctuating wholesale prices are reshaping how energy costs are managed, making reactive approaches increasingly inadequate.
